[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100597165":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":24,"responsibleParty":41,"collaborators":10,"id":45,"slug":10,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":65,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"University of Rochester","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Indocyanine Green (ICG) and KARL STORZ ICG Imaging System",null,[12],"Diagnostic Test: ICG (Indocyanine Green)",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","ICG (Indocyanine Green)","Lymphatic mapping",[9],[20],{"name":21,"role":22,"phone":10,"phoneExt":10,"email":23},"Abdelhafeez Abdelhafeez, MD","CONTACT","Abdelhafeez_Abdelhafeez@URMC.Rochester.edu",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"University of Rochester Medical Center","RECRUITING","Rochester","New York","14642","United States",{"type":33,"coordinates":34},"Point",[35,36],-77.61556,43.15478,{"lat":36,"lon":35},[39],{"name":40,"role":22,"phone":10,"phoneExt":10,"email":23},"Abdelhafeez Abdelhafeez",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Hafeez Abdel","Associate Professor - Department of Surgery, Pediatric Surgery (SMD)","100597165",false,"NCT07054944","Tumor-Lymph Node Mapping","FEASIBILITY AND SAFETY OF INDOCYANINE GREEN (ICG) GUIDED SENTINEL LYMPH NODE MAPPING FOR PEDIATRIC SOLID TUMORS - T-LyM (Tumor-Lymph Node Mapping)","T-LyM","Inclusion Criteria:\n\n* Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery.\n* Diagnosed with pediatric solid tumor\n* Scheduled to undergo lymph node sampling as part of their clinical management.\n\nExclusion Criteria:\n\n* Subjects with a history of iodide allergies.\n* Inability or unwillingness of research participant or parent\u002Flegal guardian to give written informed consent.\n* Currently pregnant.\n* Infants under 650 grams.\n* Patients with extensive prior surgery at the primary site or nodal basin expected to affect the lymphatic drainage.","ALL","1 Month","17 Years",{"count":56,"type":57},10,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection\u002Fsampling.\n\nThis trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.",[61,62,63,64],"Pediatric Solid Tumors","Rhabdomyosarcoma","Sarcoma","Germ Cell Tumor",[66],"PEDIATRIC CANCER","2026-04-20",{"date":69,"type":70},"2026-04-23","ACTUAL",{"date":72,"type":57},"2026-04-13",{"date":74,"type":57},"2028-07-30",{"name":5,"class":6},1]